Omentin as a novel biomarker of metabolic risk factors

Diabetology and Metabolic Syndrome

Volumn 4, Issue 1, 2012, Pages

  Shibata, Rei ^a   Ouchi, Noriyuki ^a   Takahashi, Ryotaro ^b   Terakura, Yuya ^a   Ohashi, Koji ^a   Ikeda, Nobuo ^b   Higuchi, Akiko ^a   Terasaki, Hiroko ^c   Kihara, Shinji ^c   Murohara, Toyoaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Chunichi Hospital   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Adipocytokine; Biomarkers; Metabolic disorders; Omentin; Risk factors

Indexed keywords

ADIPOCYTOKINE; BIOLOGICAL MARKER; OMENTIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CORRELATION ANALYSIS; DYSLIPIDEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE INTOLERANCE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; METABOLIC DISORDER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; WAIST CIRCUMFERENCE;

EID: 84864131930     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-4-37     Document Type: Article

References (18)

1. Overweight and obesity in the united states: Prevalence and trends, 1960-1994. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL, Int (Pubitemid 28036587)
2. Obesity and cardiovascular disease: Is body structure a factor' Nielsen S, Jensen MD, Curr Opin Lipidol 1997 8 200 204 10.1097/00041433-199708000-00002 9253535 (Pubitemid 27354586)
3. Abdominal obesity and metabolic syndrome. Despres JP, Lemieux I, Nature 2006 444 881 887 10.1038/nature05488 17167477 (Pubitemid 46024995)
4. Therapy insight: Adipocytokines in metabolic syndrome and related cardiovascular disease. Matsuzawa Y, Nat Clin Pract Cardiovasc Med. 2006 3 35 42 10.1038/ncpcardio0380 16391616 (Pubitemid 43078211)
5. Adipokines in inflammation and metabolic disease. Ouchi N, Parker JL, Lugus JJ, Walsh K, Nat Rev Immunol 2011 11 85 97 10.1038/nri2921 21252989
6. Obesity, adiponectin and vascular inflammatory disease. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K, Curr Opin Lipidol 2003 14 561 566 10.1097/00041433-200312000-00003 14624132 (Pubitemid 41623184)
7. Adiponectin and cardiovascular disease. Shibata R, Ouchi N, Murohara T, Circ J 2009 73 608 614 10.1253/circj.CJ-09-0057 19261992
8. Adipokines, myokines and cardiovascular disease. Walsh K, Circ J 2009 73 13 18 10.1253/circj.CJ-08-0961 19043226
9. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: Possible role in modulating insulin action. Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, Hansen BC, Shuldiner AR, Fried SK, McLenithan JC, Gong DW, Am J Physiol Endocrinol Metab 2006 290 1253 E1261 10.1152/ajpendo.00572.2004 16531507 (Pubitemid 43847911)
10. Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Schaffler A, Neumeier M, Herfarth H, Furst A, Scholmerich J, Buchler C, Biochim Biophys Acta 2005 1732 96 102 10.1016/j.bbaexp.2005.11.005 16386808 (Pubitemid 43267310)
11. Human intelectin is a novel soluble lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall. Tsuji S, Uehori J, Matsumoto M, Suzuki Y, Matsuhisa A, Toyoshima K, Seya T, J Biol Chem 2001 276 23456 23463 10.1074/jbc.M103162200 11313366
12. Omentin plasma levels and gene expression are decreased in obesity. de Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J, Ndubuizu K, Patil S, Schwartz A, Kligman M, Fried SK, Gong DW, Shuldiner AR, Pollin TI, McLenithan JC, Diabetes 2007 56 1655 1661 10.2337/db06-1506 17329619 (Pubitemid 46842600)
13. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Pan HY, Guo L, Li Q, Diabetes Res Clin Pract. 2010 88 29 33 10.1016/j.diabres.2010.01.013 20129687
14. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: Ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Tan BK, Adya R, Farhatullah S, Lewandowski KC, O'Hare P, Lehnert H, Randeva HS, Diabetes 2008 57 801 808 10.2337/db07-0990 18174521
15. Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. Yamawaki H, Tsubaki N, Mukohda M, Okada M, Hara Y, Biochem Biophys Res Commun 2010 393 668 672 10.1016/j.bbrc.2010.02.053 20170632
16. Association of a fat-derived plasma protein omentin with carotid artery intima-media thickness in apparently healthy men. Shibata R, Takahashi R, Kataoka Y, Ohashi K, Ikeda N, Kihara S, Murohara T, Ouchi N, Hypertens Res 2011 34 1309 1312 10.1038/hr.2011.130 21814208
17. Association of serum omentin-1 levels with coronary artery disease. Zhong X, Zhang HY, Tan H, Zhou Y, Liu FL, Chen FQ, Shang DY, Acta Pharmacol Sin. 2011 32 873 878 10.1038/aps.2011.26 21602837
18. Circulating omentin is associated with coronary artery disease in men. Shibata R, Ouchi N, Kikuchi R, Takahashi R, Takeshita K, Kataoka Y, Ohashi K, Ikeda N, Kihara S, Murohara T, Atherosclerosis 2011 219 2 811 4 10.1016/j.atherosclerosis.2011.08.017 21925659